強直性脊椎炎治療薬の世界市場2018

• 英文タイトル:Global Ankylosing Spondylitis Drug Sales Market Report 2018

Global Ankylosing Spondylitis Drug Sales Market Report 2018「強直性脊椎炎治療薬の世界市場2018」(市場規模、市場予測)調査レポートです。• レポートコード:D107252
• 出版社/出版日:QYResearch / 2018年10月
• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User License¥436,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥872,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、強直性脊椎炎治療薬の世界市場について調査・分析し、強直性脊椎炎治療薬のメーカー別販売量、市場シェア分析、種類別販売分析(シミジア、エンブレル、フミラ、レミケード、シンプニー、その他)、用途別販売分析(病院、クリニック)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、強直性脊椎炎治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・強直性脊椎炎治療薬市場概要
・強直性脊椎炎治療薬のメーカー別販売量・メーカー別シェア
・強直性脊椎炎治療薬の世界市場:種類別販売量(シミジア、エンブレル、フミラ、レミケード、シンプニー、その他)
・強直性脊椎炎治療薬の世界市場:用途別販売量(病院、クリニック)
・強直性脊椎炎治療薬の世界市場:地域別販売量・市場シェア
・強直性脊椎炎治療薬の米国市場規模
・強直性脊椎炎治療薬の中国市場規模
・強直性脊椎炎治療薬の欧州市場規模
・強直性脊椎炎治療薬の日本市場規模
・強直性脊椎炎治療薬の東南アジア市場規模
・強直性脊椎炎治療薬のインド市場規模
・強直性脊椎炎治療薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・強直性脊椎炎治療薬のコスト分析・価格動向
・強直性脊椎炎治療薬の産業チェーン(サプライチェーン分析)
・強直性脊椎炎治療薬のマーケティング戦略・販売チャネル、流通業者
・強直性脊椎炎治療薬市場への影響要因分析
・強直性脊椎炎治療薬の世界市場予測
・強直性脊椎炎治療薬の米国市場予測
・強直性脊椎炎治療薬の中国市場予測
・強直性脊椎炎治療薬の欧州市場予測
・強直性脊椎炎治療薬の日本市場予測
・強直性脊椎炎治療薬の東南アジア市場予測
・強直性脊椎炎治療薬のインド市場予測
・強直性脊椎炎治療薬の種類別世界市場予測(シミジア、エンブレル、フミラ、レミケード、シンプニー、その他)
・強直性脊椎炎治療薬の用途別世界市場予測(病院、クリニック)
...

This report studies the global Ankylosing Spondylitis Drug market status and forecast, categorizes the global Ankylosing Spondylitis Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Ankylosing spondylitis is a form of chronic inflammation of the spine and the sacroiliac joints.
The global Ankylosing Spondylitis Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai
Pfizer
Johnson & Johnson

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Cimzia
Enbrel
Humira
Remicade
Simponi
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Clinics

The study objectives of this report are:
To analyze and study the global Ankylosing Spondylitis Drug sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Ankylosing Spondylitis Drug players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Ankylosing Spondylitis Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Ankylosing Spondylitis Drug Manufacturers
Ankylosing Spondylitis Drug Distributors/Traders/Wholesalers
Ankylosing Spondylitis Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Ankylosing Spondylitis Drug market, by end-use.
Detailed analysis and profiles of additional market players.

レポート目次

Table of Contents

Global Ankylosing Spondylitis Drug Sales Market Report 2018
1 Ankylosing Spondylitis Drug Market Overview
1.1 Product Overview and Scope of Ankylosing Spondylitis Drug
1.2 Classification of Ankylosing Spondylitis Drug by Product Category
1.2.1 Global Ankylosing Spondylitis Drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Ankylosing Spondylitis Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Cimzia
1.2.4 Enbrel
1.2.5 Humira
1.2.6 Remicade
1.2.7 Simponi
1.2.8 Others
1.3 Global Ankylosing Spondylitis Drug Market by Application/End Users
1.3.1 Global Ankylosing Spondylitis Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospitals
1.3.2 Clinics
1.4 Global Ankylosing Spondylitis Drug Market by Region
1.4.1 Global Ankylosing Spondylitis Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Ankylosing Spondylitis Drug Status and Prospect (2013-2025)
1.4.3 Europe Ankylosing Spondylitis Drug Status and Prospect (2013-2025)
1.4.4 China Ankylosing Spondylitis Drug Status and Prospect (2013-2025)
1.4.5 Japan Ankylosing Spondylitis Drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Ankylosing Spondylitis Drug Status and Prospect (2013-2025)
1.4.7 India Ankylosing Spondylitis Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Ankylosing Spondylitis Drug (2013-2025)
1.5.1 Global Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2025)
1.5.2 Global Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2025)

2 Global Ankylosing Spondylitis Drug Competition by Players/Suppliers, Type and Application
2.1 Global Ankylosing Spondylitis Drug Market Competition by Players/Suppliers
2.1.1 Global Ankylosing Spondylitis Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Ankylosing Spondylitis Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Ankylosing Spondylitis Drug (Volume and Value) by Type
2.2.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Ankylosing Spondylitis Drug (Volume and Value) by Region
2.3.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Ankylosing Spondylitis Drug (Volume) by Application

3 United States Ankylosing Spondylitis Drug (Volume, Value and Sales Price)
3.1 United States Ankylosing Spondylitis Drug Sales and Value (2013-2018)
3.1.1 United States Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
3.1.2 United States Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Ankylosing Spondylitis Drug Sales Price Trend (2013-2018)
3.2 United States Ankylosing Spondylitis Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Ankylosing Spondylitis Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Ankylosing Spondylitis Drug Sales Volume and Market Share by Application (2013-2018)

4 Europe Ankylosing Spondylitis Drug (Volume, Value and Sales Price)
4.1 Europe Ankylosing Spondylitis Drug Sales and Value (2013-2018)
4.1.1 Europe Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
4.1.2 Europe Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
4.1.3 Europe Ankylosing Spondylitis Drug Sales Price Trend (2013-2018)
4.2 Europe Ankylosing Spondylitis Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Ankylosing Spondylitis Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Ankylosing Spondylitis Drug Sales Volume and Market Share by Application (2013-2018)

5 China Ankylosing Spondylitis Drug (Volume, Value and Sales Price)
5.1 China Ankylosing Spondylitis Drug Sales and Value (2013-2018)
5.1.1 China Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
5.1.2 China Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
5.1.3 China Ankylosing Spondylitis Drug Sales Price Trend (2013-2018)
5.2 China Ankylosing Spondylitis Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Ankylosing Spondylitis Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Ankylosing Spondylitis Drug Sales Volume and Market Share by Application (2013-2018)

6 Japan Ankylosing Spondylitis Drug (Volume, Value and Sales Price)
6.1 Japan Ankylosing Spondylitis Drug Sales and Value (2013-2018)
6.1.1 Japan Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Ankylosing Spondylitis Drug Sales Price Trend (2013-2018)
6.2 Japan Ankylosing Spondylitis Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Ankylosing Spondylitis Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Ankylosing Spondylitis Drug Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Ankylosing Spondylitis Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Ankylosing Spondylitis Drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Ankylosing Spondylitis Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Ankylosing Spondylitis Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Ankylosing Spondylitis Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Ankylosing Spondylitis Drug Sales Volume and Market Share by Application (2013-2018)

8 India Ankylosing Spondylitis Drug (Volume, Value and Sales Price)
8.1 India Ankylosing Spondylitis Drug Sales and Value (2013-2018)
8.1.1 India Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
8.1.2 India Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
8.1.3 India Ankylosing Spondylitis Drug Sales Price Trend (2013-2018)
8.2 India Ankylosing Spondylitis Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Ankylosing Spondylitis Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Ankylosing Spondylitis Drug Sales Volume and Market Share by Application (2013-2018)

9 Global Ankylosing Spondylitis Drug Players/Suppliers Profiles and Sales Data
9.1 Amgen
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Amgen Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Wyeth
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Wyeth Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Takeda
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Takeda Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Centocor
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Centocor Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Schering-Plough
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Schering-Plough Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Mitsubishi Tanabe
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Abbott
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Abbott Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Eisai
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Eisai Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Pfizer
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Pfizer Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Johnson & Johnson
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview

10 Ankylosing Spondylitis Drug Maufacturing Cost Analysis
10.1 Ankylosing Spondylitis Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Ankylosing Spondylitis Drug
10.3 Manufacturing Process Analysis of Ankylosing Spondylitis Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Ankylosing Spondylitis Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Ankylosing Spondylitis Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Ankylosing Spondylitis Drug Market Forecast (2018-2025)
14.1 Global Ankylosing Spondylitis Drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Ankylosing Spondylitis Drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Ankylosing Spondylitis Drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Ankylosing Spondylitis Drug Price and Trend Forecast (2018-2025)
14.2 Global Ankylosing Spondylitis Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Ankylosing Spondylitis Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Ankylosing Spondylitis Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Ankylosing Spondylitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Ankylosing Spondylitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Ankylosing Spondylitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Ankylosing Spondylitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Ankylosing Spondylitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Ankylosing Spondylitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Ankylosing Spondylitis Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Ankylosing Spondylitis Drug Sales Forecast by Type (2018-2025)
14.3.2 Global Ankylosing Spondylitis Drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Ankylosing Spondylitis Drug Price Forecast by Type (2018-2025)
14.4 Global Ankylosing Spondylitis Drug Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Ankylosing Spondylitis Drug
Figure Global Ankylosing Spondylitis Drug Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Ankylosing Spondylitis Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Cimzia Product Picture
Figure Enbrel Product Picture
Figure Humira Product Picture
Figure Remicade Product Picture
Figure Simponi Product Picture
Figure Others Product Picture
Figure Global Ankylosing Spondylitis Drug Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Ankylosing Spondylitis Drug by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Global Ankylosing Spondylitis Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Ankylosing Spondylitis Drug Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Ankylosing Spondylitis Drug Sales Volume (K Units) (2013-2018)
Table Global Ankylosing Spondylitis Drug Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Ankylosing Spondylitis Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Ankylosing Spondylitis Drug Sales Share by Players/Suppliers
Figure 2017 Ankylosing Spondylitis Drug Sales Share by Players/Suppliers
Figure Global Ankylosing Spondylitis Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Ankylosing Spondylitis Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Ankylosing Spondylitis Drug Revenue Share by Players
Table 2017 Global Ankylosing Spondylitis Drug Revenue Share by Players
Table Global Ankylosing Spondylitis Drug Sales (K Units) and Market Share by Type (2013-2018)
Table Global Ankylosing Spondylitis Drug Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Ankylosing Spondylitis Drug by Type (2013-2018)
Figure Global Ankylosing Spondylitis Drug Sales Growth Rate by Type (2013-2018)
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Ankylosing Spondylitis Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Ankylosing Spondylitis Drug by Type (2013-2018)
Figure Global Ankylosing Spondylitis Drug Revenue Growth Rate by Type (2013-2018)
Table Global Ankylosing Spondylitis Drug Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Ankylosing Spondylitis Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Ankylosing Spondylitis Drug by Region (2013-2018)
Figure Global Ankylosing Spondylitis Drug Sales Growth Rate by Region in 2017
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Ankylosing Spondylitis Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Ankylosing Spondylitis Drug by Region (2013-2018)
Figure Global Ankylosing Spondylitis Drug Revenue Growth Rate by Region in 2017
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Ankylosing Spondylitis Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Ankylosing Spondylitis Drug by Region (2013-2018)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share by Region in 2017
Table Global Ankylosing Spondylitis Drug Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Ankylosing Spondylitis Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Ankylosing Spondylitis Drug by Application (2013-2018)
Figure Global Ankylosing Spondylitis Drug Sales Market Share by Application (2013-2018)
Figure United States Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (2013-2018)
Figure United States Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Ankylosing Spondylitis Drug Sales Price (USD/Unit) Trend (2013-2018)
Table United States Ankylosing Spondylitis Drug Sales Volume (K Units) by Players (2013-2018)
Table United States Ankylosing Spondylitis Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Ankylosing Spondylitis Drug Sales Volume Market Share by Players in 2017
Table United States Ankylosing Spondylitis Drug Sales Volume (K Units) by Type (2013-2018)
Table United States Ankylosing Spondylitis Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Ankylosing Spondylitis Drug Sales Volume Market Share by Type in 2017
Table United States Ankylosing Spondylitis Drug Sales Volume (K Units) by Application (2013-2018)
Table United States Ankylosing Spondylitis Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Ankylosing Spondylitis Drug Sales Volume Market Share by Application in 2017
Figure Europe Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Ankylosing Spondylitis Drug Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Ankylosing Spondylitis Drug Sales Volume (K Units) by Players (2013-2018)
Table Europe Ankylosing Spondylitis Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Ankylosing Spondylitis Drug Sales Volume Market Share by Players in 2017
Table Europe Ankylosing Spondylitis Drug Sales Volume (K Units) by Type (2013-2018)
Table Europe Ankylosing Spondylitis Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Ankylosing Spondylitis Drug Sales Volume Market Share by Type in 2017
Table Europe Ankylosing Spondylitis Drug Sales Volume (K Units) by Application (2013-2018)
Table Europe Ankylosing Spondylitis Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Ankylosing Spondylitis Drug Sales Volume Market Share by Application in 2017
Figure China Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (2013-2018)
Figure China Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Ankylosing Spondylitis Drug Sales Price (USD/Unit) Trend (2013-2018)
Table China Ankylosing Spondylitis Drug Sales Volume (K Units) by Players (2013-2018)
Table China Ankylosing Spondylitis Drug Sales Volume Market Share by Players (2013-2018)
Figure China Ankylosing Spondylitis Drug Sales Volume Market Share by Players in 2017
Table China Ankylosing Spondylitis Drug Sales Volume (K Units) by Type (2013-2018)
Table China Ankylosing Spondylitis Drug Sales Volume Market Share by Type (2013-2018)
Figure China Ankylosing Spondylitis Drug Sales Volume Market Share by Type in 2017
Table China Ankylosing Spondylitis Drug Sales Volume (K Units) by Application (2013-2018)
Table China Ankylosing Spondylitis Drug Sales Volume Market Share by Application (2013-2018)
Figure China Ankylosing Spondylitis Drug Sales Volume Market Share by Application in 2017
Figure Japan Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Ankylosing Spondylitis Drug Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Ankylosing Spondylitis Drug Sales Volume (K Units) by Players (2013-2018)
Table Japan Ankylosing Spondylitis Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Ankylosing Spondylitis Drug Sales Volume Market Share by Players in 2017
Table Japan Ankylosing Spondylitis Drug Sales Volume (K Units) by Type (2013-2018)
Table Japan Ankylosing Spondylitis Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Ankylosing Spondylitis Drug Sales Volume Market Share by Type in 2017
Table Japan Ankylosing Spondylitis Drug Sales Volume (K Units) by Application (2013-2018)
Table Japan Ankylosing Spondylitis Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Ankylosing Spondylitis Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Ankylosing Spondylitis Drug Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Ankylosing Spondylitis Drug Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Ankylosing Spondylitis Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Ankylosing Spondylitis Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Ankylosing Spondylitis Drug Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Ankylosing Spondylitis Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Ankylosing Spondylitis Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Ankylosing Spondylitis Drug Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Ankylosing Spondylitis Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Ankylosing Spondylitis Drug Sales Volume Market Share by Application in 2017
Figure India Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (2013-2018)
Figure India Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Ankylosing Spondylitis Drug Sales Price (USD/Unit) Trend (2013-2018)
Table India Ankylosing Spondylitis Drug Sales Volume (K Units) by Players (2013-2018)
Table India Ankylosing Spondylitis Drug Sales Volume Market Share by Players (2013-2018)
Figure India Ankylosing Spondylitis Drug Sales Volume Market Share by Players in 2017
Table India Ankylosing Spondylitis Drug Sales Volume (K Units) by Type (2013-2018)
Table India Ankylosing Spondylitis Drug Sales Volume Market Share by Type (2013-2018)
Figure India Ankylosing Spondylitis Drug Sales Volume Market Share by Type in 2017
Table India Ankylosing Spondylitis Drug Sales Volume (K Units) by Application (2013-2018)
Table India Ankylosing Spondylitis Drug Sales Volume Market Share by Application (2013-2018)
Figure India Ankylosing Spondylitis Drug Sales Volume Market Share by Application in 2017
Table Amgen Basic Information List
Table Amgen Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Ankylosing Spondylitis Drug Sales Growth Rate (2013-2018)
Figure Amgen Ankylosing Spondylitis Drug Sales Global Market Share (2013-2018)
Figure Amgen Ankylosing Spondylitis Drug Revenue Global Market Share (2013-2018)
Table Wyeth Basic Information List
Table Wyeth Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Wyeth Ankylosing Spondylitis Drug Sales Growth Rate (2013-2018)
Figure Wyeth Ankylosing Spondylitis Drug Sales Global Market Share (2013-2018)
Figure Wyeth Ankylosing Spondylitis Drug Revenue Global Market Share (2013-2018)
Table Takeda Basic Information List
Table Takeda Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Ankylosing Spondylitis Drug Sales Growth Rate (2013-2018)
Figure Takeda Ankylosing Spondylitis Drug Sales Global Market Share (2013-2018
Figure Takeda Ankylosing Spondylitis Drug Revenue Global Market Share (2013-2018)
Table Centocor Basic Information List
Table Centocor Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Centocor Ankylosing Spondylitis Drug Sales Growth Rate (2013-2018)
Figure Centocor Ankylosing Spondylitis Drug Sales Global Market Share (2013-2018)
Figure Centocor Ankylosing Spondylitis Drug Revenue Global Market Share (2013-2018)
Table Schering-Plough Basic Information List
Table Schering-Plough Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Schering-Plough Ankylosing Spondylitis Drug Sales Growth Rate (2013-2018)
Figure Schering-Plough Ankylosing Spondylitis Drug Sales Global Market Share (2013-2018)
Figure Schering-Plough Ankylosing Spondylitis Drug Revenue Global Market Share (2013-2018)
Table Mitsubishi Tanabe Basic Information List
Table Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales Growth Rate (2013-2018)
Figure Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales Global Market Share (2013-2018
Figure Mitsubishi Tanabe Ankylosing Spondylitis Drug Revenue Global Market Share (2013-2018)
Table Abbott Basic Information List
Table Abbott Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Ankylosing Spondylitis Drug Sales Growth Rate (2013-2018)
Figure Abbott Ankylosing Spondylitis Drug Sales Global Market Share (2013-2018)
Figure Abbott Ankylosing Spondylitis Drug Revenue Global Market Share (2013-2018)
Table Eisai Basic Information List
Table Eisai Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eisai Ankylosing Spondylitis Drug Sales Growth Rate (2013-2018)
Figure Eisai Ankylosing Spondylitis Drug Sales Global Market Share (2013-2018
Figure Eisai Ankylosing Spondylitis Drug Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Ankylosing Spondylitis Drug Sales Growth Rate (2013-2018)
Figure Pfizer Ankylosing Spondylitis Drug Sales Global Market Share (2013-2018)
Figure Pfizer Ankylosing Spondylitis Drug Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Ankylosing Spondylitis Drug Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Ankylosing Spondylitis Drug Sales Global Market Share (2013-2018)
Figure Johnson & Johnson Ankylosing Spondylitis Drug Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ankylosing Spondylitis Drug
Figure Manufacturing Process Analysis of Ankylosing Spondylitis Drug
Figure Ankylosing Spondylitis Drug Industrial Chain Analysis
Table Raw Materials Sources of Ankylosing Spondylitis Drug Major Players in 2017
Table Major Buyers of Ankylosing Spondylitis Drug
Table Distributors/Traders List
Figure Global Ankylosing Spondylitis Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Ankylosing Spondylitis Drug Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Ankylosing Spondylitis Drug Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Ankylosing Spondylitis Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Ankylosing Spondylitis Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Ankylosing Spondylitis Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Ankylosing Spondylitis Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Ankylosing Spondylitis Drug Revenue and Growth Rate Forecast (2018-2025)
Figure China Ankylosing Spondylitis Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Ankylosing Spondylitis Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Ankylosing Spondylitis Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Ankylosing Spondylitis Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Ankylosing Spondylitis Drug Sales (K Units) Forecast by Type (2018-2025)
Figure Global Ankylosing Spondylitis Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Ankylosing Spondylitis Drug Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Ankylosing Spondylitis Drug Sales (K Units) Forecast by Application (2018-2025)
Figure Global Ankylosing Spondylitis Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



• 英文レポート名:Global Ankylosing Spondylitis Drug Sales Market Report 2018
• 日本語訳:強直性脊椎炎治療薬の世界市場2018
• レポートコード:D107252お問い合わせ(見積依頼・ご注文・質問)